Adiva Tablet

About Adiva 600 mg Tablet

Adiva 600 mg Tablet is an anti-retroviral medicine used in the treatment of HIV-1 infection. It belongs to a group of drugs called non-nucleoside reverse transcriptase inhibitors, which work by interfering with the way the virus copies itself.

There are 2 brands of Efavirenz listed in Bangladesh. 1 of them has a lower unit price than Adiva.

What is Adiva 600 mg Tablet?

Adiva 600 mg Tablet contains efavirenz, an anti-retroviral medicine that acts against HIV-1. It works by blocking the enzyme activities the virus needs to replicate, so the virus cannot multiply as it normally would. It is not used on its own; doctors prescribe it together with other anti-retroviral agents as part of a combination treatment plan. Adiva is made by Square Pharmaceuticals PLC and comes as a tablet in a pack of 1 x 10. The doctor decides the dose and course that suit each person.

Uses of Adiva

Adiva 600 mg Tablet is used together with other anti-retroviral agents for the treatment of HIV-1 infection in adults and in children, according to what the doctor advises. It is a non-nucleoside reverse transcriptase inhibitor. It is not a stand-alone treatment and should not be started without a doctor's guidance, since HIV therapy is planned as a combination.

How to use Adiva

Adiva 600 mg Tablet is taken by mouth. The dose, the timing and how long it is taken are decided by the doctor, who considers the person's age, weight and other medicines. Do not change the dose or stop taking it on your own. If a dose is missed or extra is taken, contact the doctor or pharmacist for advice. Ask the doctor about any food instructions.

Side effects of Adiva

Like other medicines, Adiva 600 mg Tablet can cause side effects. These may include rash, dizziness, headache, sleep problems, unusual dreams, confusion, nausea, vomiting, diarrhoea and tiredness. Some people develop changes in mood or thinking, and other effects are possible. If any side effect troubles you or becomes severe, tell the doctor promptly. The doctor can advise on what to do.

Safety and precautions

Tell the doctor before starting Adiva 600 mg Tablet if you have a history of seizures or mental health problems, liver or kidney problems, or porphyria. It should not be used by anyone allergic to it, by people with severe liver impairment, or during breastfeeding. It is not to be taken with certain other medicines, so give the doctor a full list of what you use. Pregnancy needs special discussion with the doctor. Ask the doctor first if any of these apply to you.

Frequently asked questions

What is the price of Adiva 600 mg Tablet?

The listed price is ৳ 200.7. Ask your pharmacist about the current price and availability, as prices can change.

How should Adiva 600 mg Tablet be taken?

It is taken by mouth. The doctor decides the dose, timing and length of treatment for you. Do not change the dose or stop it without the doctor's advice, and ask the doctor or pharmacist if you are unsure about anything.

What is Adiva 600 mg Tablet used for and what kind of medicine is it?

It is an anti-retroviral medicine used together with other drugs to treat HIV-1 infection. It belongs to the non-nucleoside reverse transcriptase inhibitor group and works by interfering with how the virus copies itself.

Who should avoid Adiva 600 mg Tablet or ask the doctor first?

Ask the doctor first if you have liver or kidney problems, seizures, mental health problems or porphyria, or if you are pregnant or breastfeeding. It should not be used by people allergic to it or with severe liver impairment, or with certain other medicines.

Indications

Efavirenz in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection. This indication is based on analyses of plasma HIV- RNA levels and CD4 cell counts in controlled studies of up to 24 weeks in duration. At present, there are no results from controlled trials evaluating long term suppression of HIVRNA with Efavirenz.

Pharmacology

Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against HIV-1. It blocks the RNA- and DNA-dependent polymerase activities including HIV-1 replication.

Dosage & Administration

Adults: The recommended dosage of Efavirenz is 600 mg orally, once daily, in combination with a protease inhibitor and/or nucleoside analogue reverse transcriptase inhibitors (NRTIs).

Pediatric Patients: Following table describes the recommended dose of Efavirenz for pediatric patients 3 years of age or older and weighing between 10 and 40 kg. The recommended dosage of Efavirenz for pediatric patients weighing greater than 40 kg is 600 mg, once daily.
  • 10 to <15  kg: 200 mg
  • 15 to < 20 kg: 250 mg
  • 20 to < 25 kg: 300 mg
  • 25 to < 32.5 kg: 350 mg
  • 32.5 to < 40 kg: 400 mg
  • 40 kg: 600 mg

Interaction

Additive CNS effects w/ psychoactive drugs. May alter plasma warfarin concentrations. May reduce plasma concentrations of HIV integrase inhibitors (e.g. dolutegravir), other HIV NNRTIs (e.g. etravirine), HMG-CoA reductase inhibitors (e.g. simvastatin). Plasma concentrations of efavirenz is increased and that of voriconazole is reduced when given concomitantly. Reduced plasma concentrations w/ rifampicin.

Contraindications

Hypersensitivity. Severe hepatic impairment. Lactation. Concomitant admin with terfenadine, astemizole, cisapride, midazolam, triazolam, pimozide, bepridil, ergot alkaloids, St John’s wort.

Side Effects

Rashes, psychiatric or CNS disturbances, amnesia, agitation, confusion, dizziness, vertigo, headache, euphoria, insomnia or somnolence, impaired concentration, abnormal thinking or dreaming, depersonalisation, convulsions, hallucinations, nausea, vomiting, diarrhoea, pancreatitis, fatigue, hepatic failure, photoallergic dermatitis; autoimmune disorders (e.g. Graves’ disease, polymyositis, Guillain-Barre syndrome), osteonecrosis. Accumulation or redistribution of body fat (lipodystrophy) including central obesity, peripheral and facial wasting, buffalo hump, breast enlargement, cushingoid appearance. Metabolic abnormalities e.g. hypercholesterolaemia, hyperglycaemia, hypertriglyceridaemia, hyperlactataemia, insulin resistance.

Pregnancy & Lactation

Category D: There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).

Lactation: Efavirenz may pass through breast milk and cause serious harm to the baby. It should not be used during lactation.

Precautions & Warnings

Patient with history of seizures and psychiatric disorders; acute porphyria. Patients receiving voriconazole or rifampicin (weighing ≥50 kg). Discontinue if severe rash or fever develops. Moderate hepatic and severe renal impairment. Childn. Pregnancy.

Overdose Effects

Symptoms: Increased adverse CNS effects including involuntary muscle contractions.

Management: Supportive and symptomatic treatment. May administer activated charcoal.

Alternative brands of Efavirenz

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.